Hidden cancer risks for Hysterectomy and Fibroid Removal
Posted in Drug & Medical Devices on July 10, 2015
Uterine cancer is the fourth most common cancer in women in the United States and the most commonly diagnosed gynecologic cancer. Prior to a hysterectomy or fibroid removal (myomectomy), the FDA estimates that approximately 1 in 350 women have an unsuspected uterine sarcoma, a type of uterine cancer that includes leiomyosarcoma. Stages of Endometrial...
J&J Pulls Hysterectomy Tool Due to Cancer Risk
Posted in Drug & Medical Devices on August 1, 2014
Johnson & Johnson has asked all hospitals to return a surgical device that can spread cancer in women being treated for uterine growths called fibroids. The company has instituted a voluntary “worldwide market withdrawal” of the surgical tool known as a laparoscopic power morcellator. During laparoscopic hysterectomies and myomectomies, surgeons use a power morcellator...
Fibroid Treatment May Spread Hidden Cancer
Posted in Drug & Medical Devices on April 23, 2014
The FDA has issued a warning that certain surgical procedures used to treat uterine fibroids can cause the spread of undetected cancer. What are Fibroids? A uterine fibroid is a tumor that grows in the wall of the uterus. While many women who develop fibroids experience no symptoms, those who do may require surgery...
Gynecologists Question Robotic Hysterectomies
Posted in Drug & Medical Devices on May 29, 2013
[caption id="attachment_904" align="alignright" width="155"] da Vinci Surgical Robot System©2013 Intuitive Surgical, Inc.[/caption] One in nine women will undergo a hysterectomy during her lifetime, making it one of the most common surgical procedures for women. With more and more women opting for robotic hysterectomies, the president of the American College of Obstetrics and Gynecologists (ACOG),...